Le Lézard
Classified in: Science and technology
Subjects: CALENDAR OF EVENTS, TRADE SHOWS/SEMINARS/WEBINARS

Sylogist to Participate in the CIBC Technology & Innovation Conference


CALGARY, Alberta, May 17, 2023 (GLOBE NEWSWIRE) -- Sylogist Ltd. (TSX:SYZ) ("Sylogist" or the "Company"), a leading public sector SaaS company, is pleased to announce that President and Chief Executive Officer Bill Wood will present at the CIBC Technology & Innovation Conference 11.0 in Toronto, Ontario on Wednesday, May 24, 2023 at 9:45 a.m. Eastern Time. Mr. Wood and Sujeet Kini, Sylogist's Chief Financial Officer, will also host meetings with institutional investors on that day.

About Sylogist
Sylogist provides mission-critical SaaS solutions to over 2,000 public sector customers globally across the government, nonprofit, and education verticals. The Company's stock is traded on the Toronto Stock Exchange under the symbol SYZ. Information about Sylogist, inclusive of full financial statements together with Management's Discussion and Analysis, can be found at www.sylogist.com.

For further information contact:

Sujeet Kini, Chief Financial Officer
or
Rudy Shirra, Director of Business Development and Operations Strategy

Sylogist Ltd.
(403) 266-4808
[email protected]



These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

18 mai 2024
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: